105 related articles for article (PubMed ID: 6432041)
1. Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.
Law SK; Minich TM; Levine RP
Biochemistry; 1984 Jul; 23(14):3267-72. PubMed ID: 6432041
[TBL] [Abstract][Full Text] [Related]
2. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
3. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
4. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Gigli I; Fujita T; Nussenzweig V
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
[TBL] [Abstract][Full Text] [Related]
6. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
Volanakis JE
Year Immunol; 1989; 4():218-30. PubMed ID: 2648703
[No Abstract] [Full Text] [Related]
7. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
[TBL] [Abstract][Full Text] [Related]
9. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
10. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.
Campbell RD; Gagnon J; Porter RR
Biochem J; 1981 Nov; 199(2):359-70. PubMed ID: 6978711
[TBL] [Abstract][Full Text] [Related]
11. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.
Kerr MA; Parkes C
Biochem J; 1984 Apr; 219(2):391-9. PubMed ID: 6611150
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
Nicholson-Weller A; Burge J; Fearon DT; Weller PF; Austen KF
J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
[No Abstract] [Full Text] [Related]
14. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Parker CJ; Baker PJ; Rosse WF
J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of the C3 convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography.
Nagasawa S; Kobayashi C; Maki-Suzuki T; Yamashita N; Koyama J
J Biochem; 1985 Feb; 97(2):493-9. PubMed ID: 3874204
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
17. Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.
Kossorotow A; Opitz W; Etschenberg E; Hadding U
Biochem J; 1977 Nov; 167(2):377-82. PubMed ID: 597250
[TBL] [Abstract][Full Text] [Related]
18. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
Loos M; Heinz HP
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():67-74. PubMed ID: 6375257
[TBL] [Abstract][Full Text] [Related]
19. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
20. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
Pangburn MK; Müller-Eberhard HJ
Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
